Avadel Pharmaceuticals Plc financial data

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland
Fiscal year end
December 31
Former names
FLAMEL TECHNOLOGIES SA (to 12/30/2016)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 304 % +32.2%
Quick Ratio 30.1 %
Debt-to-equity 108 % -56.5%
Return On Equity -93.3 % +71.5%
Return On Assets -44.8 % +52.3%
Operating Margin -46.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.4M shares +7.3%
Common Stock, Shares, Outstanding 96.3M shares +7.76%
Entity Public Float 1.46B USD +926%
Common Stock, Value, Issued 963K USD +7.84%
Weighted Average Number of Shares Outstanding, Basic 96.3M shares +7.74%
Weighted Average Number of Shares Outstanding, Diluted 96.3M shares +7.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 138M USD +613%
Research and Development Expense 13.3M USD -22.5%
Costs and Expenses 144M USD +46.3%
Operating Income (Loss) -64M USD +52.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -73M USD +54.2%
Income Tax Expense (Benefit) -428K USD -35.4%
Net Income (Loss) Attributable to Parent -72.6M USD +54.3%
Earnings Per Share, Basic -0.75 USD/shares +65.3%
Earnings Per Share, Diluted -0.75 USD/shares +65.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.6M USD -44.8%
Marketable Securities, Current 37.2M USD -63.3%
Accounts Receivable, after Allowance for Credit Loss, Current 37.1M USD +495%
Inventory, Net 16.1M USD +205%
Other Assets, Current 1.95M USD +150%
Assets, Current 127M USD -26.1%
Property, Plant and Equipment, Net 469K USD -27.6%
Operating Lease, Right-of-Use Asset 1.93M USD -31.2%
Goodwill 16.8M USD 0%
Other Assets, Noncurrent 11.8M USD +15.9%
Assets 158M USD -22.1%
Accounts Payable, Current 7.92M USD -40.3%
Accrued Liabilities, Current 33.9M USD +88.8%
Liabilities, Current 42.8M USD -20.9%
Operating Lease, Liability, Noncurrent 1.22M USD -36.9%
Other Liabilities, Noncurrent 5.15M USD -11.4%
Liabilities 83.6M USD -10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23.8M USD +8.28%
Retained Earnings (Accumulated Deficit) -789M USD -10.1%
Stockholders' Equity Attributable to Parent 74.7M USD -32.2%
Liabilities and Equity 158M USD -22.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD +1.75%
Net Cash Provided by (Used in) Financing Activities 13.2M USD -61.7%
Net Cash Provided by (Used in) Investing Activities 21.4M USD +322%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.3M shares +7.76%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.63M USD -50.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.6M USD -44.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 730K USD -76.1%
Deferred Tax Assets, Valuation Allowance 96.4M USD +35.2%
Deferred Tax Assets, Gross 96.4M USD +35%
Operating Lease, Liability 2.62M USD +50.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -70.4M USD +55.1%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD +66.1%
Operating Lease, Liability, Current 725K USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 683K USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.09M USD +7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +60%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 420K USD +352%
Lessee, Operating Lease, Liability, to be Paid, Year Three 477K USD +132%
Deferred Tax Assets, Operating Loss Carryforwards 71.1M USD +33.1%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 3.04M USD -3.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 477K USD
Preferred Stock, Shares Outstanding 0 shares -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%